Patent · US Active

Recombinant hemoglobins and methods of preparation and use thereof

US10752672B1 · kind B1 · utility

1Cited by
1References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 31, 2020
Grant dateAug 25, 2020
Priority date
Expiry dateJan 31, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12P21/00
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure relates to recombinant hemoglobins with improved oxygen carrying capacity and methods of preparation and use thereof. The present disclosure also relates to a pharmaceutical composition including the recombinant hemoglobin useful for treating oxygen deficiency related diseases or conditions, such as stroke, hemorrhagic shock, peripheral arterial disease (PAD), acute mountain sickness (AMS), cancer, and Parkinson's disease (PD).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.